ArticleThoracic cancer2021

Autologous cytokine-induced killer (CIK) cells enhance the clinical response to PD-1 blocking antibodies in patients with advanced non-small cell lung cancer: A preliminary study.

Ying Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.